Certified by Founder Lodge
Maven Capital Partners
United Kingdom - Glasgow
INVESTOR
1 Disclosed Funding Rounds $6,170,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Maven Capital Partners (a subsidiary of Mattioli Woods plc) is a leading VCT, Private Equity and Property Fund Manager.
We back growing businesses of all sizes across a range of sectors, p
| Company | Date | Round | Raised |
|---|---|---|---|
 Manufacture 2030 | M2030 |
March, 30 ,2023 | Series A | $6,170,000 |
 Pockit |
August, 07 ,2023 | Unknown | $10,000,000 |
 Laverock Therapeutics |
September, 28 ,2023 | Seed | $16,470,000 |
 Drovo |
October, 25 ,2023 | Unknown | $3,638,000 |
 Metrion Biosciences |
December, 21 ,2023 | Unknown | $4,672,767 |
 Carcinotech Ltd |
January, 30 ,2024 | Unknown | $5,330,157 |
 Zing Dev Limited |
May, 02 ,2024 | Unknown | $1,565,212 |
 RwHealth |
June, 14 ,2024 | Series A | $1,746,791 |
Founderpath
Truework
Finix
Farther
TeamApt Inc.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
